 | Not many places left for COVID to evade immunity: UK vaccine creatorThe expert said that such viruses, by their very nature tend to become less virulent over time, but there is no set timeframe for how long that would take. |
 | Single dose of Astrazeneca, Pfizer vaccines cut COVID infection rate significantly, confirms studyThree weeks after people had been given a single dose of either of the vaccine, the rates of all COVID-19 infections fell by 65%. |
 | EU drug regulator confirms AstraZeneca blood clot link but says COVID jab still safeNo specific risk factors, including age, have been identified for thrombosis with the AstraZeneca shot, which could stem from an immune response, the European Medicines Agency (EMA) said. |
 | IAVI, Merck KGaA, Serum Institute join hands to develop monoclonal antibodies for COVID-19Under IAVI's agreement with Merck KGaA and Serum Institute, the partners will conduct an accelerated, integrated program of preclinical and clinical research to evaluate the antibodies. |
 | If everything goes well India would get COVID-19 vaccine by year-end: Harsh VardhanThree COVID-19 vaccine candidates, including two indigenous ones, are in different phases of development in India. |
